Bax does not have to adopt its final form to drive T cell death by Zhu, Yanan et al.
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It is by now well known that the death of many 
types of cells under many circumstances in-
volves members of the Bcl-2 family of proteins 
(1–3). The Bcl-2 family has been subdivided by 
structural considerations and known functions 
into three subcategories (1–3). Some of the 
proteins, called “protectors,” are almost always 
antiapoptotic. Other Bcl-2–related proteins, 
called “messengers,” are thought to monitor 
the status of various parts of the cell and deliver 
the signal to the cell to die. A third subcategory 
of Bcl-2–related proteins is thought to execute 
cell death, hence the name of this family, “exe-
cutioners.” Bak and Bax are members of this 
subcategory (4, 5).
Others have previously shown, however, 
that one of the two executioners, Bak or Bax, 
is required for the death of activated T cells (5) 
and that, in embryonic fi  broblasts at least, the 
action of the messengers requires expression of 
either Bak or Bax (6). The means whereby the 
messengers induce the action of the execution-
ers remains unresolved. There is some under-
standing, however, about the way in which the 
executioners kill cells. Thus, Bak and Bax 
change their shape during cell death (7–10), as 
detected by antibodies against peptides near the 
NH2 terminus (Nter) of the proteins. Determi-
nants recognized by the antibodies are masked 
in Bak and Bax in healthy cells, but are revealed 
when the proteins change their shapes during 
cell death (9, 11). After changing their shape, 
Bak and Bax aggregate and may form pores in 
the outer membrane of mitochondria (12–17), 
for example, leading to loss of mitochondrial 
potential, release of cytochrome c, and death of 
the cell.
Here we examine these events in activated 
T cells as they die. Resting, activated, and dy-
ing T cells all contain about the same amounts 
of the executioners, Bak or Bax. Most of the 
Bak in the T cells, regardless of their state, is 
membrane bound, probably on mitochondria, 
as reported previously (9). Some of this Bak 
changes its shape before the T cells die, as de-
tected by a polyclonal anti-BakNter antibody. 
In contrast, most of the Bax in T cells is cyto-
plasmic before the T cells die, as detected by 
a monoclonal anti-BaxNter antibody. Only a 
small amount of the Bax is bound to mem-
branes (18), and only a small proportion of the 
Bax changes its shape. This is true even if the 
T cells lack Bak. Thus, the death of activated 
T cells requires Bak or Bax, but death is not 
necessarily preceded by a large change in the 
location of the executioner protein or by a 
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  completely unfolded form until after the cells are dead.
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conversion of the executioner protein to its terminal, fully 
oligomerized form. Some intermediate form of the execu-
tioner proteins may actually drive death of the cell.
RESULTS AND DISCUSSION
Rapid death of activated T cells requires either Bak or Bax
Activated T cells die rapidly in animals after antigen has dis-
appeared (19–21). To fi  nd out if this death were dependent 
on Bak or Bax, Bak KO or Bak KO and control animals were 
injected with the Vβ8-engaging superantigen, staphylococcal 
enterotoxin B (SEB), and tested 2 and 7 d later for their num-
bers of Vβ8+ T cells. Vβ8+ T cells lacking either Bak or Bax 
expanded and died in vivo in response to SEB with normal 
kinetics (Fig. 1, A–D). Similar results were observed in vitro. 
Bak KO or Bax KO and its wild-type littermates were given 
SEB. 2 d later, their T cells were harvested, cultured for vari-
ous lengths of time, and monitored for the percentage of ac-
tivated Vβ8+ T cells that had died (21). As shown in Fig. 1 
(E–H), activated CD4+ or CD8+ T cells lacking Bak or Bax 
died at the same rate as those from wild-type mice, and much 
more rapidly than resting T cells. To check whether Bak or 
Bax was needed at all for this in vitro death, we activated T 
cells lacking both Bak and Bax (produced in chimeric mice) 
and compared their rates of death with those of T cells lack-
ing only Bak (Fig. 1, I and J). As expected, activated T cells 
lacking Bak died rapidly. Activated T cells lacking both Bak 
and Bax, however, died very slowly. Thus, as others have 
shown (5), either Bak or Bax is required for the rapid death 
of activated T cells, and the two proteins appear to act inter-
changeably and with similar kinetics.
Changes in the conformation of Bak, but not Bax, precede 
activated T cell death
Bak and Bax change their conformation during cell death, 
measured by the fact that antibodies against peptide sequences 
near the Nter ends of these proteins (anti-BakNter, anti-
BaxNter; references 7–11) do not react with the proteins in 
healthy cells, but do react when the cells are dead. We used 
microscopy to follow these changes in conformation of Bak 
and Bax during T cell death. Healthy resting T cells were 
obtained from unimmunized mice. Activated cells that were 
preparing to die and activated dead T cells were obtained by 
sorting live and dead Vβ8+ cells that had been activated with 
SEB in vivo, isolated 2–3 d later, and cultured for 12 h, at 
which time about half of the cells are dead and 20% are des-
tined to die in the next 12 h (Fig. 1). Resting T cells did not 
stain above the background (determined with Bak KO or 
Bax KO T cells) with anti-BakNter or anti-BaxNter. Dead 
activated T cells stained strongly with either antibody. 
Healthy T cells that were preparing to die stained quite well 
with anti-BakNter but poorly with anti-BaxNter (Fig. 2 A).
To quantitate these results, we measured the intensity of 
staining of individual cells with anti-BakNter or anti-
BaxNter. Anti-BakNter had a low level of background stain-
ing on Bak KO–activated T cells. Wild-type resting T cells 
stained at about the same level as Bak KO T cells, indicating 
that no Bak was in the unfolded state in these cells. Live acti-
vated T cells that had been cultured to bring them to the 
brink of death, on the other hand, stained quite well with the 
anti-BakNter, and dead activated T cells stained even more 
intensely (Fig. 2, B and D).
Figure 1.  Activated T cell death requires either Bak or Bax. 
(A–D) BL6, Bak KO, Bax KO, and Bax+/+ littermates of Bax KO mice were 
injected with 100 ug SEB i.v. At the indicated times, cells were harvested 
from spleens and the percentage of CD4+ or CD8+ T cells bearing Vβ8x was 
determined. Closed and open symbols represent the results for KO and 
wild-type mice, respectively. Results shown are means ± standard devia-
tions of data from three mice at each time point. (E–J) BL6, Bak KO, Bax 
KO, Bax+/+, and RAG KO mice reconstituted with Bak KO or Bak KO Bax 
KO bone marrow were given SEB. 63 h later, T cells were purifi  ed from 
their spleens and lymph nodes and cultured. At various times thereafter, 
the percentages of CD4+ and CD8+ Vβ8+ T cells that were alive, as 
 defi  ned by their light scatter properties (reference 29), were determined. 
(E and F) ●, SEB-injected Bak KO; ○, SEB-injected BL/6; □, uninjected 
Bak KO cells. (G and H) ▲, SEB-injected Bax KO; △, SEB-injected Bax+/+ 
littermates; □, uninjected Bax KO cells. (I and J) ◆, SEB-injected Rag KO 
mice reconstituted with Bak KO Bax KO fetal liver cells; ●, SEB-injected 
Rag KO mice reconstituted with Bak KO fetal liver cells. (E, G, and I) Re-
sults for CD4+ T cells. (F, H, and J) Results for CD8+ T cells. Results shown 
are means ± standard deviations of data from three samples analyzed at 
each time point in one experiment. Results are also illustrative of two 
independent experiments for the Bak KO Bax KO T cells and of more than 
four independent experiments for the Bak KO and Bax KO cells.JEM VOL. 203, May 15, 2006  1149
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Anti-BaxNter had some background staining on Bax 
KO–activated T cells (Fig. 2 C), and, again, levels of staining 
with this antibody of wild-type resting T cells were not above 
the background. As before, anti-BaxNter staining of activated 
live T cells, cultured to bring them close to death, was only 
barely brighter than that of resting T cells or Bax KO T cells. 
Dead activated T cells, on the other hand, stained well with 
anti-BaxNter (Fig. 2, C and E).
Thus, quite a lot of Bak changes its shape in activated T 
cells before they die, but most of the Bax does not expose its 
Nter sequence until after the cells are dead.
Bim acts upstream of Bak or Bax
We and others have reported that activated T cells lacking 
Bim (Bim KO) die slowly (22–24). To fi  nd out whether Bim 
acts before or after Bak or Bax in the events leading to T cell 
death, we studied whether Bim was needed for Bak or Bax to 
change its shape as T cells prepare to die. T cells were har-
vested from SEB-immunized Bim KO and wild-type mice 
and cultured for a short time. The cells were then sorted to 
purify the cells bearing Vβ8, stained with anti-BakNter or 
anti-BaxNter, and analyzed as described above.
As before, living activated wild-type cells contained a 
considerable amount of Bak that had changed its shape 
and was now detectable with the anti-BakNter antibody. 
  However, the change of Bak was barely detectable in cells 
lacking Bim (Fig. 3). Bax did not detectably change its shape 
at all in Bim KO T cells (not depicted). Thus, in activated 
T cells, Bim is involved in the change in confi  guration of 
Bak, which precedes cell death.
Absence of Bak does not affect the kinetics with which Bax 
changes its shape
These results suggested that Bak might be more crucial 
than Bax to the death of activated T cells. However, as 
shown in Fig. 1, activated T cells that lack Bak die at the 
same rate as wild-type cells (Fig. 1). Therefore, we pre-
dicted that in the absence of Bak, Bax might change its 
shape more extensively. To test this, activated T cells from 
C57BL/6 (BL6) and Bak KO mice were cultured, sorted 
for live and dead cells based on propidium iodide (PI) stain-
ing, and stained with anti-BaxNter. The intensity of anti-
BaxNter staining/cell was estimated as before. The BL6 
cells stained poorly with anti-BaxNter (Figs. 2, C and E, 
and 4). The dead activated Bak KO T cells stained very 
well with anti-BaxNter. Surprisingly, however, the stain-
ing of live activated Bak KO T cells with anti-BaxNter was 
barely above that of the BL6 cells (Fig. 4). These results 
were confi  rmed by attempts to use the anti-BaxNter to 
  immunoprecipitate Bax from Bak KO or BL6 resting, acti-
vated, or activated cells that were preparing to die. Under 
no circumstances could we see evidence of precipitation 
with the antibody (not depicted).
These results show that the kinetics with which Bax 
changes its conformation are not aff  ected very much by 
the absence of Bak from the cells, and suggest that just a 
small amount of conversion, if any, of Bax to its supposed 
death-dealing, fully converted form is suffi   cient to drive 
cell death.
Figure 2.  Before activated T cells die, a considerable amount of 
Bak, but not Bax, changes its shape. BL6 mice were injected with 100 ug 
SEB. 2 d later, T cells were isolated from their spleens and lymph nodes 
and cultured for 7 h. The cells were then sorted based on PI staining to 
obtain Vβ8+ live and dead populations, and stained for NterBak or Nter-
Bax. (A) Typical fi  elds of the different types of cells are shown. (B–E) Indi-
vidual cells were ringed and analyzed for their extent of NterBak (B and D) 
or NterBax (C and E) staining and surface area. The level of staining of 
each cell was corrected for background levels of staining, with the follow-
ing calculation: [(the amount of staining with the particular antibody/
surface area) − (background staining/surface area)] × surface area. The 
cells were then assigned to bins based on their level of staining with each 
antibody. Results shown are as follows: (the number of cells in each bin/
total number of cells analyzed) × 100. Results represent analyses of at 
least 226 live cells and 21 dead cells of each type. The experiments shown 
in B and D and in C and E were performed at different times. Settings and 
conditions were slightly different between the two experiments shown, 
which led to differences in the level of anti-Bax staining of activated cells.1150  BAX CONFORMATION AND T CELL DEATH | Zhu et al. 
Bax does not change its location when T cells are activated
The executioners, Bak and Bax, are thought to act by dis-
rupting the integrity of intracellular membranes, particularly 
those of the mitochondria (12–17). Because most of the Bax 
in healthy cells is cytoplasmic (18), we thought that Bax 
might translocate to membranes as T cells prepared to die and 
that such movement might be particularly marked in cells 
lacking Bak. To check this, T cells were isolated from normal 
or 3 d SEB-primed BL6 mice. The cells were lysed by pas-
sage through a homogenizer. The lysates were cleared of in-
tact cells and nuclei by a low speed spin. Heavy membranes, 
which include mitochondria, were then prepared with an in-
termediate speed spin. The heavy membrane and supernatant 
fractions were then Western blotted.
Control proteins were found in the expected fraction, 
Tom20 was found in the heavy membrane fraction, and lac-
tate dehydrogenase was found in the supernatant. Resting 
and activated T cells contained about the same amount of Bax. 
Only  10% of the Bax in the cell was in the heavy mem-
brane fraction, regardless of whether or not the T cells had 
been activated (Fig. 5 A and Fig. S1, which is available at 
http://www.jem.org/cgi/content/full/jem.20051736/DC1).
Similar experiments were performed with cells from Bak 
KO mice. In this case, there was somewhat more Bax/106 
cells in the heavy membrane fractions from activated T cells 
than in the fractions from resting T cells, a result we observed 
intermittently in the activated T cell preparations. The in-
crease in Bax was paralleled by a similar increase in the 
amount of Tom20 in the heavy membrane fractions, such 
that the ratio of Bax/Tom20 remained constant within the 
diff  erent types of cells, suggesting that the result is due to an 
overall increase in the numbers of mitochondria in activated 
versus resting T cells. In spite of this, the amounts of Bax and 
Tom20 in the heavy membrane fractions were unaff  ected by 
incubation of the activated T cells to bring them closer to 
death (Fig. 5 B and Fig. S2, which is available at http://
www.jem.org/cgi/content/full/jem.20051736/DC1).
These experiments showed that the amount of Bax associ-
ated with heavy membranes changes only slightly when cells 
are activated, and that the concentration of Bax/heavy mem-
brane probably remains constant regardless of the activation 
Figure 3.  The change in shape of Bak during T cell death requires 
Bim. Bim KO and Bim+/+ littermates were immunized with SEB as de-
scribed in the legend to Fig. 2. Live Vβ8x+ T cells were purifi  ed by cell 
sorting, stained with anti-NterBak, and analyzed as described in the leg-
end to Fig. 2. Results shown are the percentages of cells of each type 
that fell into each bin, calculated as described in the legend to Fig. 2. 
Anti-NterBak staining of at least 226 cells of each type was analyzed.
Figure 4.  The extent to which Bax changes its shape during cell 
death is only slightly affected by lack of Bak. Cells were prepared, 
stained, and analyzed as described in the legend to Fig. 2. Results shown 
are the percentages of cells of each type that fell into each bin, calculated 
as described in the legend to Fig. 2. Bax staining in at least 292 live cells 
of either type and 79 dead cells was analyzed.
Figure 5.  The amount of Bax bound to heavy membranes does not 
change before T cells die. (A) Vβ8x T cells were activated in BL6 mice 
with SEB. 3 d later, T cells were isolated from the animals and cultured for 
7 h. Live Vβ8x T cells were isolated by cell sorting and homogenized with-
out detergent. Homogenates were made from resting T cells and heavy 
membrane and cytosol fractions prepared from each homogenate, run on 
SDS PAGE, and Western blotted for the indicated proteins. Cell equivalents 
run in each lane are shown at the bottom of the panel. (B) BAK KO mice 
were immunized with 100 ug SEB. 3 d later, spleen and lymph node T cells 
were isolated from these and other unimmunized (Rest.) BAK KO mice. 
Half of the T cells from the immunized BAK KO mice were incubated for 5 h 
to bring them closer to death (Act. inc.). The other half were kept on ice 
(Act.). Live cells were then purifi  ed from all the samples, and heavy mem-
brane and cytosol fractions were prepared, run on SDS PAGE, and Western 
blotted as described in A. Blots shown are representative of at least three 
independent experiments.JEM VOL. 203, May 15, 2006  1151
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state or Bak content of the cell. Moreover, Bax does not 
change its conformation, as judged by its anti-Nter monoclo-
nal antibody, before the T cells die. We believe these results 
have three interpretations. First, Bax may move to mem-
branes, change its shape, as defi  ned by the monoclonal anti-
BaxNter antibody, and deliver its lethal hit to the Bak 
KO–activated T cell exactly at the moment the T cell dies. 
This is a possibility that we certainly cannot dismiss. However, 
in the microscopy experiments described here, T cell death 
was defi  ned by permeability to PI or Ficoll/diatrizoate, which 
is loss of plasma membrane integrity. This is a relatively late 
event in T cell death. T cells expose phosphatidyl serine and 
thus bind annexin V, and lose their mitochondrial function 
before their plasma membranes become permeable. Second, 
Bax may not have to change its levels on heavy membranes or 
change its shape to deliver its lethal hit to T cells. The native 
form of Bax, defi  ned by nuclear magnetic resonance experi-
ments (25) may, under some circumstances, be able to do the 
job. Finally, Bax may have several conformations. One is 
folded as discerned in the nuclear magnetic resonance analyses 
(25) and is harmless to the cell. A second conformation may 
be analogous to the form of Bak detected by the polyclonal 
anti–Bak21-35 antisera. We suggest that this conformation of 
Bax does not react with the anti–Bax12-24 monoclonal anti-
body, and it is this form of Bax and the analogous form of Bak 
that actually kill the cell. A third conformation of Bax may be 
represented by completely unfolded, aggregated protein. This 
form reacts with the anti–BaxNter12-24 monoclonal antibody 
and appears only after the cell is dead.
We prefer the last of these hypotheses because we think it 
unlikely that Bak and Bax act in such diff  erent ways to kill 
cells. An additional thought in favor of the last hypothesis is 
the fact that the anti–BakNter23-35 antisera and anti-BaxNter 
monoclonal antibody do not react with exactly analogous 
stretches of the two proteins. The determinant recognized by 
the anti-BakNter antisera actually lies a little COOH-termi-
nal of the determinant recognized by the anti–BaxNter12-24 
monoclonal antibody. Therefore, it is possible that the inter-
mediate death-dealing form of the two proteins has a partial 
shape change near the end of its fi  rst α helix, exposing the 
determinant recognized by anti–Bak21-35. Only after un-
folding of the proteins is complete do their NH2 termini 
  become completely accessible to antibodies such as the 
anti–BaxNter12-24.
In summary, these experiments support the idea that ei-
ther Bak or Bax is needed for the death of activated T cells, 
with either acting downstream of Bim. However, under cir-
cumstances in which death is entirely dependent on Bax, as 
in Bak KO T cells, dramatic changes in the amount and loca-
tion of Bax and complete unfolding of the protein are not 
needed. Perhaps some intermediate form of the protein is the 
actual executioner of T cell death.
MATERIALS AND METHODS
Mice. BL6 mice were purchased from The Jackson Laboratory. VβDO ani-
mals, expressing a transgene for a Vβ8.2+ T cell receptor β chain (26), were 
bred in the Biological Resource Center at the National Jewish Medical and 
Research Center. Bak KO (4), Bax KO (27), and Bim KO (22) mice were 
bred from animals provided by T. Lindsten and C. Thompson (University of 
Pennsylvania, Philadelphia, PA), S. Korsmeyer (Harvard University, Boston, 
MA), and P. Bouillet and A. Strasser (Walter and Eliza Hall Institute, Mel-
bourne, Australia). Because we have been unable to produce live Bak KO 
Bax KO double KO mice in our facility, double KO T cells were obtained 
from chimeric mice prepared as follows. Bak KO Bax KO fetuses were ob-
tained at day 15 of pregnancy from Bak KO Bax+/− females mated with Bak 
KO Bax+/− males. Fetal livers were harvested from the mice, and cell sus-
pensions from the birds were frozen in 90% FBS, 10% DMSO. Embryos 
were typed by PCR for Bax genotype. Fetal liver cells from the appropriate 
mice were transferred into lethally irradiated BL6 recipients. T cells were 
  activated and harvested from these mice 8 wk later.
Vβ8+ T cells were activated in vivo as described previously (21) by i.v. 
injection of 100 ug SEB 2–3 d before harvest of the cells.
All animals were maintained in the Biological Resource Center of the 
National Jewish Medical and Research Center under specifi  c pathogen-free 
conditions and in accordance with federal guidelines approved by the 
  National Jewish Institutional Animal Care and Use Committee.
T cell preparation, staining, and isolation by sorting. T cells were 
purifi  ed by passage over nylon wool columns. In some cases, they were cul-
tured for 5–12 h in complete culture medium at 37°C. Live cells were puri-
fi  ed on lymphocyte separation medium (Ficoll/diatrizoate; MP Biomedicals) 
step gradients or by sorting. To isolate live and dead cells, cells were cul-
tured, stained with anti-Vβ8x and PI as described previously, and sorted into 
live and dead populations based on PI staining (28). The cells were then 
stained with anti-BakNter or anti-BaxNter and DAPI and analyzed as 
  described in Results.
Immunofl  uorescence  microscopy. Lymph node cells were harvested 
from BL6, VβDO, Bak KO, or Bax KO mice that had been injected with 
150 μg SEB 2 d previously. T cells were purifi  ed by passage through nylon 
wool columns, and Vβ8+ T cells were purifi  ed by fl  ow cytometry (except 
for cells from VβDO animals, for which purifi  cation was not necessary). 
Some of the activated T cells were cultured for 5–12 h to bring them closer 
to death. In this case, live and dead cells were subsequently purifi  ed by cell 
sorting. Resting T cells were harvested from similar unmanipulated mice and 
purifi  ed simply by passage through nylon wool columns. Aliquots of the ac-
tivated T cells were cultured for 18 h to confi  rm their rapid death in vitro. 
Resting, activated, and activated plus cultured T cells were then loaded onto 
coverslips pretreated with 100 μg/ml poly-l-lysine and incubated at 37°C 
for 10 min. Immobilized cells were fi  xed with prewarmed 3% paraformalde-
hyde at 37°C for 15 min and permeabilized with 0.2% CHAPS (3-[(3-
  cholamidopropyl)-dimethylammonio]-1-propanesulfonate; Pierce Chemical 
Co.). CHAPS was used to avoid untoward induction of conformational 
changes in Bak or Bax (11). Permeabilized cells were blocked with DMEM 
plus 5% FBS for 30 min and incubated with anti-BaxNter (catalog no. 06-
499; Upstate Biotechnology) or anti-BakNter (catalog no. 06-536; Upstate 
Biotechnology) for 2 h, and then with Alexa Fluor 488– or Alexa Fluor 
647–conjugated anti–rabbit IgG for 1 h. A wash of six changes of PBS was 
applied after each antibody incubation. Finally, the cells were stained with 
1 μM Hoechst 33342 for 5 min and mounted onto slides. Visual data were 
acquired by examining slides under a Leica DMXRA epifl  uorescence mi-
croscope equipped with a SensiCam CCD camera (PCO CCD Imaging) 
and analyzed with SlideBook software (Intelligent Imaging Innovations).
Subcellular fractionation by diff  erential sedimentation and analysis 
by Western blotting. T cells were resuspended at a concentration of 4.5 × 
107 cells/ml in ice-cold mitochondrial buff  er (200 mM mannitol, 70 mM 
sucrose, 10 mM Hepes, 1 mM EDTA, 1 mM EGTA, pH 7.5; reference 7) 
supplemented with 0.1 mM PMSF, 1 mM DTT, and the protease inhibitor 
cocktail, Complete Mini (Roche Diagnostics). Homogenization was per-
formed in a ball-bearing homogenizer (H&Y Enterprise) with 20 strokes. 1152  BAX CONFORMATION AND T CELL DEATH | Zhu et al. 
Cell lysates were centrifuged twice at 950 g for 15 min to pellet out the nu-
clei and intact cells. The supernatants were then centrifuged at 10,000 g for 
25 min to acquire the mitochondria-enriched heavy membrane fraction. 
Proteins were separated by SDS-PAGE on Criterion 10–20% gradient gels 
(Bio-Rad Laboratories) and transferred to Hybond ECL nitrocellulose mem-
branes (GE Healthcare) by a semidry method. Membranes were blocked at 
room temperature for 1–2 h with BLOTTO (5% milk and 1% FBS in Tris-
buff  ered saline [TBS] plus 0.05% Tween-20), incubated with the primary 
antibody for 4 h, washed with several changes of TBS-T (TBS plus 0.05% 
Tween-20), and incubated with secondary antibodies for 3 h. Bound sec-
ondary antibodies were visualized by ECL detection reagents (GE Health-
care). The primary antibodies used were rabbit anti-Bak pAb (Upstate 
Biotechnology), goat anti–lactate dehydrogenase pAb (Rockland Immuno-
chemicals), rabbit anti-Bax N-20 pAb, and anti-TOM20 pAb (Santa Cruz 
Biotechnology, Inc.).
Online supplemental material. Figs. S1 and S2 show the complete gel 
bands for the Western blots shown in Fig. 5 (A and B, respectively) and are 
available at http://www.jem.org/cgi/content/full/jem.20051736/DC1.
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